E Ink, an electronic ink technology provider, and Faubel & Co Nachf have introduced a new smart label for investigational medicinal products.
Image: Waste plastic bottles. Photo: courtesy of David Jones.
The new Faubel-Med Label features E Ink’s low-voltage film technology and is developed to simplify and shorten expiry updates allowing for considerable time and cost savings.
Faubel new technologies production head Konrad Zachman said: “The Med Label is a breakthrough product that makes the handling of investigational medicinal products in clinical trial supply chains so much easier.
“As we see a continuous growth in biologic products that require frequent updates on stability data, the Med Label emerges as a cost-effective, highly-efficient smart label that meets the demands of present and future compliance requirements.”
The Med Label also features an ePaper display and a booklet label that is integrated with radio-frequency identification (RFID) technology to allow pharmaceutical packaging to be updated on demand, E Ink said.
E Ink chief strategy officer Paul Apen said: “E Ink’s smart packaging solutions are at the forefront of pharmaceutical packaging innovation.
“Adding displays to pharma packaging requires thin and flexible displays that are also low-power. Our ePaper displays are perfect for this application given their thin, low voltage properties, as well as easy readability, contrast and wide viewing angle.”
Featuring a segmented bi-stable E Ink display which provide expiry updates even on a sealed kit, the Med Label provides an alternative to relabeling for pharmaceutical companies whenever stability data changes.
Faubel managing director Frank Jäger said that the new label is a game changer that will transform clinical trials, saving the industry time and money.
Additional features of the Med Label include a battery-free, always-on ePaper display and an RFID tag which facilitates on-demand label updates for expiry dates.